Oncology
Amy Dezern, MD
Professor of Oncology and Medicine; Director, Bone Marrow Failure and MDS Program
Amy DeZern, MD, MHS, is a Professor of Oncology and Medicine at Johns Hopkins University School of Medicine in Baltimore, MD, and serves as Director of the Bone Marrow Failure (BMF) and Myelodysplastic Syndromes (MDS) Program at the Sidney Kimmel Comprehensive Cancer Center. She specializes in hematologic oncology, focusing on BMF syndromes, MDS, acute myeloid leukemia (AML), aplastic anemia, and clonal hematopoiesis. Dr. DeZern treats patients with cytopenias, myeloid neoplasms, and refractory
21+
Years in Practice
Credentials
Board Certifications
- Internal Medicine (American Board of Internal Medicine)
- Hematology (American Board of Internal Medicine)
Education & Training
- Johns Hopkins University School of Medicine — M.D.
- Johns Hopkins University — Residency, Internal Medicine
- Johns Hopkins University — Fellowship, Medical Oncology
- Johns Hopkins University — Fellowship, Hematology
- Johns Hopkins Bloomberg School of Public Health — MHS, Clinical Investigations
Peer Recognition
- CMS — Meaningful Use Stage 1 Certification
2013-2014 (2 years)
- NCI — Cancer Clinical Investigator Team Leadership Award
- Sidney Kimmel Comprehensive Cancer Center — Director’s Teaching Award
2013, 2020 (2 years)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
- Johns Hopkins Hospital
Languages
English
Experience
21+ years in practice